- AEGR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $30.6 million.
- AEGR has traded 106,747 shares today.
- AEGR is down 3.1% today.
- AEGR was up 7.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AEGR with the Ticky from Trade-Ideas. See the FREE profile for AEGR NOW at Trade-Ideas More details on AEGR: Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. Currently there are 7 analysts that rate Aegerion Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Aegerion Pharmaceuticals has been 1.1 million shares per day over the past 30 days. Aegerion has a market cap of $953.8 million and is part of the health care sector and drugs industry. The stock has a beta of 0.23 and a short float of 44.7% with 10.02 days to cover. Shares are down 51.2% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.